Concomitant medications and risk of chemotherapy‐induced peripheral neuropathy
L Sánchez‐Barroso, M Apellaniz‐Ruiz… - The …, 2019 - academic.oup.com
Background Peripheral neuropathy is the dose‐limiting toxicity of many oncology drugs,
including paclitaxel. There is large interindividual variability in the neuropathy, and several
risk factors have been proposed; however, many have not been replicated. Here we present
a comprehensive study aimed at identifying treatment and physiopathology‐related
paclitaxel‐induced neuropathy risk factors in a large cohort of well‐characterized patients.
Patients and Methods Analyses included 503 patients with breast or ovarian cancer who …
including paclitaxel. There is large interindividual variability in the neuropathy, and several
risk factors have been proposed; however, many have not been replicated. Here we present
a comprehensive study aimed at identifying treatment and physiopathology‐related
paclitaxel‐induced neuropathy risk factors in a large cohort of well‐characterized patients.
Patients and Methods Analyses included 503 patients with breast or ovarian cancer who …
[PDF][PDF] Concomitant Medications and Risk of Chemotherapy-Induced Peripheral Neuropathy
SB LARA, M APELLANIZ-RUIZ… - Breast, 2018 - researchgate.net
Background. Peripheral neuropathy is the dose-limiting toxicity of many oncology drugs,
including paclitaxel. There is large interindividual variability in the neuropathy, and several
risk factors have been proposed; however, many have not been replicated. Here we present
a comprehensive study aimed at identifying treatment and physiopathology-related
paclitaxel-induced neuropathy risk factors in a large cohort of well-characterized patients.
Patients and Methods. Analyses included 503 patients with breast or ovarian cancer who …
including paclitaxel. There is large interindividual variability in the neuropathy, and several
risk factors have been proposed; however, many have not been replicated. Here we present
a comprehensive study aimed at identifying treatment and physiopathology-related
paclitaxel-induced neuropathy risk factors in a large cohort of well-characterized patients.
Patients and Methods. Analyses included 503 patients with breast or ovarian cancer who …
以上显示的是最相近的搜索结果。 查看全部搜索结果